跳至主要内容
临床试验/JPRN-UMIN000028756
JPRN-UMIN000028756已完成未知

An exploratory clinical study on the safety of combination therapy with effector cell therapy and immune checkpoint inhibitors. - An exploratory clinical study on the safety of combination therapy with effector cell therapy and immune checkpoint inhibitors.

KOUSHIKAI,Non-profitmedicalcorporation0 个研究点目标入组 10 人开始时间: 2017年8月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • A patient MUST NOT: (1)Have treated with immune checkpoint inhibitors. (2)Be a female who is pregnant, lactating, or with a possibility of pregnancy. (3)Be determined to be inappropriate by the doctor in charge.

研究者

发起方
KOUSHIKAI,Non-profitmedicalcorporation

相似试验

An exploratory clinical study on the safety of... | 临床试验